BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38734797)

  • 21. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
    Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
    J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cicatricial pemphigoid with circulating IgA and IgG autoantibodies to the central portion of the BP180 ectodomain: beneficial effect of adjuvant therapy with high-dose intravenous immunoglobulin.
    Leverkus M; Georgi M; Nie Z; Hashimoto T; Bröcker EB; Zillikens D
    J Am Acad Dermatol; 2002 Jan; 46(1):116-22. PubMed ID: 11756957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute blistering disease presenting IgG autoantibodies against NC16A and COOH-terminal domains of BP180 and laminin-332, with characteristic distribution of eruptions.
    Kurashige Y; Minemura T; Nagatani T; Koga H; Hashimoto T
    Eur J Dermatol; 2013; 23(1):109-10. PubMed ID: 23306276
    [No Abstract]   [Full Text] [Related]  

  • 24. A case of childhood bullous pemphigoid with IgG and IgA autoantibodies to various domains of BP180.
    Osawa M; Ueda-Hayakawa I; Isei T; Yoshimura K; Fukuda S; Hashimoto T; Okamoto H
    J Am Acad Dermatol; 2014 Jun; 70(6):e129-31. PubMed ID: 24831331
    [No Abstract]   [Full Text] [Related]  

  • 25. Case report: Mucous membrane pemphigoid with complicated autoantibody profile indicating the necessity of comprehensive diagnostic methods and the contribution of IgA autoantibodies.
    Liu W; Li H; Jin Y; Cheng L; Shi L; Gao Y; Zhou Z; Feng S; Qian H; Hashimoto T; Li X
    Front Immunol; 2023; 14():1149119. PubMed ID: 36969205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain.
    Kromminga A; Sitaru C; Meyer J; Arndt R; Schmidt E; Christophers E; Bröcker EB; Zillikens D
    J Dermatol Sci; 2002 Jan; 28(1):68-75. PubMed ID: 11916132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of anti-BP180 type mucous membrane pemphigoid treated with intravenous immunoglobulin.
    Aoki N; Nakajima K; Shiga T; Koga H; Hashimoto T; Sano S
    J Dermatol; 2014 Jun; 41(6):557-9. PubMed ID: 24909219
    [No Abstract]   [Full Text] [Related]  

  • 28. Mapping of epitopes on the BP180 ectodomain targeted by IgA and IgG autoantibodies in patients with the lamina lucida-type of linear IgA disease.
    Georgi M; Scheckenbach C; Kromminga A; Partscht K; Messer G; Bröcker EB; Zillikens D
    Arch Dermatol Res; 2001 Mar; 293(3):109-14. PubMed ID: 11357223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-BP180-type mucous membrane pemphigoid immunoglobulin G shows heterogeneity of internalization of BP180/collagen XVII into keratinocyte cytoplasm.
    Imanishi A; Imanishi H; Hiroyasu S; Ozawa T; Koga H; Ishii N; Kitajima Y; Hashimoto T; Tsuruta D
    Med Mol Morphol; 2016 Jun; 49(2):89-97. PubMed ID: 26658728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases.
    Csorba K; Schmidt S; Florea F; Ishii N; Hashimoto T; Hertl M; Kárpáti S; Bruckner-Tuderman L; Nishie W; Sitaru C
    Orphanet J Rare Dis; 2011 May; 6():31. PubMed ID: 21619684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case of pemphigoid involving skin and mucous membrane with immunoglobulin G autoantibodies targeted to BP180 and laminin-332.
    Hosoda S; Suzuki M; Komine M; Fujita E; Yamada T; Murata S; Koga H; Hashimoto T; Ohtsuki M
    J Dermatol; 2013 Dec; 40(12):1067-8. PubMed ID: 24330181
    [No Abstract]   [Full Text] [Related]  

  • 32. Fc-binding proteins enhance autoantibody-induced BP180 depletion in pemphigoid.
    Iwata H; Kamaguchi M; Ujiie H; Ujiie I; Natsuga K; Nishie W; Shimizu H
    J Pathol; 2019 Mar; 247(3):371-380. PubMed ID: 30426510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Four Japanese patients with cicatricial pemphigoid showing both IgG and IgA antibodies against the 180 kDa bullous pemphigoid antigen.
    Hashimoto T; Han-Yaku H; Higashiyama M; Hashimoto K; Iwatsuki K; Kaneko F; Murakami H; Nishikawa T
    Br J Dermatol; 1997 Aug; 137(2):305-6. PubMed ID: 9292089
    [No Abstract]   [Full Text] [Related]  

  • 34. A case of cicatricial pemphigoid with simultaneous IgG autoantibodies against the 180 kd bullous pemphigoid antigen and laminin 5.
    Kawahara Y; Amagai M; Ohata Y; Ishii K; Hasegawa Y; Hsu R; Yee C; Yancey KB; Nishikawa T
    J Am Acad Dermatol; 1998 Apr; 38(4):624-7. PubMed ID: 9555805
    [No Abstract]   [Full Text] [Related]  

  • 35. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
    Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
    Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis.
    Horváth B; Niedermeier A; Podstawa E; Müller R; Hunzelmann N; Kárpáti S; Hertl M
    Exp Dermatol; 2010 Jul; 19(7):648-53. PubMed ID: 20500772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180.
    Mai Y; Nishie W; Izumi K; Shimizu H
    Front Immunol; 2019; 10():1224. PubMed ID: 31191560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of mucous membrane pemphigoid with IgG antibodies against the β3 and γ2 subunits of laminin-332, and the C-terminal domain of BP180.
    Yasumizu M; Imanishi H; Morita S; Fukuda A; Tateishi C; Koga H; Hashimoto T; Tsuruta D
    Int J Dermatol; 2018 Jan; 57(1):86-88. PubMed ID: 29130487
    [No Abstract]   [Full Text] [Related]  

  • 39. Checkpoint Inhibition May Trigger the Rare Variant of Anti-LAD-1 IgG-Positive, Anti-BP180 NC16A IgG-Negative Bullous Pemphigoid.
    Sadik CD; Langan EA; Grätz V; Zillikens D; Terheyden P
    Front Immunol; 2019; 10():1934. PubMed ID: 31474998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BP180 as the common autoantigen in blistering diseases with different clinical phenotypes.
    Zillikens D
    Keio J Med; 2002 Mar; 51(1):21-8. PubMed ID: 11951375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.